Company Information

CIN
Status
Date of Incorporation
09 February 2011
State / ROC
Ahmedabad / ROC Ahmedabad
Last Balance Sheet
31 March 2023
Last Annual Meeting
30 September 2023
Paid Up Capital
100,000
Authorised Capital
100,000

Directors

Hetal Kaushal Shah
Hetal Kaushal Shah
Director
almost 3 years ago
Nazneen Hamid
Nazneen Hamid
Director/Designated Partner
about 3 years ago
Sanjaykumar Jitendrabhai Jha
Sanjaykumar Jitendrabhai Jha
Individual Promoter
almost 15 years ago

Registered Trademarks

Synoldi Synergy Pharmasource

[Class : 5] Pharmaceuticals, Medicinal And Ayurvedic Preparations Included In Class 05.

Documents

Form MGT-7-17112019_signed
Form ADT-1-16112019_signed
Form AOC-4-26102019_signed
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-23102019
Directors report as per section 134(3)-23102019
List of share holders, debenture holders;-23102019
Copy of resolution passed by the company-21102019
Copy of written consent given by auditor-21102019
Form MSME FORM I-29052019_signed
Form MGT-7-12112018_signed
List of share holders, debenture holders;-05112018
Form AOC-4-02112018_signed
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-26102018
Directors report as per section 134(3)-26102018
Optional Attachment-(1)-26102018
Form MGT-7-02122017_signed
Form AOC-4-02122017_signed
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-27112017
Directors report as per section 134(3)-27112017
List of share holders, debenture holders;-27112017
Form 20B-12032017_signed
Form AOC-4-12032017_signed
Form MGT-7-12032017_signed
Form AOC-4-10032017_signed
Form MGT-7-10032017_signed
List of share holders, debenture holders;-06032017
Directors report as per section 134(3)-06032017
Copy of written consent given by auditor-06032017
Copy of the intimation sent by company-06032017
Copy of resolution passed by the company-06032017